Elucidating the specific pharmacological system of action (MOA) of naturally occurring compounds is usually challenging. Even though Tarselli et al. (60) created the first de novo artificial pathway to conolidine and showcased that this naturally happening compound successfully suppresses responses to both of those chemically induced and inflammation-derived pain, https://www.proleviate.com/post/conolidine-an-alternative-natural-pain-relief-to-replace-traditional-painkillers